A preliminary study on treatment of human breast cancer xenografts with a cocktail of paclitaxel, doxorubicin, and 131I-anti-epithelial cell adhesion molecule (9C4)
Triple-negative breast cancer often has devastating outcomes and treatment options remain limited. Therefore, different treatment combinations are worthy of testing. The efficacy of a cocktail of paclitaxel, doxorubicin, and 131I-anti-epithelial cell adhesion molecule (EpCAM) (9C4) to treat breast c...
Main Authors: | Naiim S Ali, John M Akudugu, Roger W Howell |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | World Journal of Nuclear Medicine |
Subjects: | |
Online Access: | http://www.wjnm.org/article.asp?issn=1450-1147;year=2019;volume=18;issue=1;spage=18;epage=24;aulast=Ali |
Similar Items
-
Biodistribution and Anti-tumor Activities of the 131I-labeled Rituximab in Nude Mice Bearing Human Burkitt’s lymphoma
by: Qiang ZUO, et al.
Published: (2009-08-01) -
Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac
by: Sudha T, et al.
Published: (2017-02-01) -
"Estudo de marcação com Iodo-131 de anticorpo monoclonal anti-CD20 usado na terapia de linfoma não-Hodgkin"
by: Akinkunmi Ganiyu Akanji
Published: (2006) -
"Estudo de marcação com Iodo-131 de anticorpo monoclonal anti-CD20 usado na terapia de linfoma não-Hodgkin"
by: Akanji, Akinkunmi Ganiyu
Published: (2006) -
TGF-β-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel
by: Wardhani BWK, et al.
Published: (2020-01-01)